Luca Shytaj
#112,505
Most Influential Person Now
Chess player
Why Is Luca Shytaj Influential?
(Suggest an Edit or Addition)According to Wikipedia, Iart Luca Shytaj is an Albanian-Italian chess grandmaster and virologist. Chess career Born on 3 February 1986, Shytaj won the Albanian Chess Championship in 2003. He earned his international master title in 2006, and won the Italian Rapid Chess Championship in 2009. He achieved his first grandmaster norm at the Arctic Chess Challenge in August 2009, his second during the 2016/17 Chess Bundesliga season, and his third at the Mulhouse Festival in July 2018. He was awarded the title in October 2018. He is the 14th Italian player to achieve the title of GM.
Luca Shytaj's Published Works
Published Works
- Dual targeting of the thioredoxin and glutathione systems in cancer and HIV. (2016) (114)
- A Highly Intensified ART Regimen Induces Long-Term Viral Suppression and Restriction of the Viral Reservoir in a Simian AIDS Model (2012) (89)
- Chloroquine and beyond: exploring anti-rheumatic drugs to reduce immune hyperactivation in HIV/AIDS (2015) (53)
- A candidate anti-HIV reservoir compound, auranofin, exerts a selective ‘anti-memory' effect by exploiting the baseline oxidative status of lymphocytes (2013) (49)
- Investigational treatment suspension and enhanced cell-mediated immunity at rebound followed by drug-free remission of simian AIDS (2013) (30)
- Potential impact of the antirheumatic agent auranofin on proviral HIV-1 DNA in individuals under intensified antiretroviral therapy: results from a randomized clinical trial. (2019) (26)
- Critical Role of IRF-8 in Negative Regulation of TLR3 Expression by Src Homology 2 Domain-Containing Protein Tyrosine Phosphatase-2 Activity in Human Myeloid Dendritic Cells (2011) (26)
- Two-Year Follow-Up of Macaques Developing Intermittent Control of the Human Immunodeficiency Virus Homolog Simian Immunodeficiency Virus SIVmac251 in the Chronic Phase of Infection (2015) (22)
- Alterations of redox and iron metabolism accompany the development of HIV latency (2020) (19)
- Glycolysis downregulation is a hallmark of HIV‐1 latency and sensitizes infected cells to oxidative stress (2021) (17)
- A cure for AIDS: a matter of timing? (2013) (15)
- Multifunctional Roles of the N-Terminal Region of HIV-1SF2Nef Are Mediated by Three Independent Protein Interaction Sites (2019) (15)
- Glycolysis downregulation is a hallmark of HIV-1 latency and sensitizes infected cells to oxidative stress (2020) (12)
- The FDA-Approved Drug Cobicistat Synergizes with Remdesivir To Inhibit SARS-CoV-2 Replication In Vitro and Decreases Viral Titers and Disease Progression in Syrian Hamsters (2022) (11)
- Custommune: a web tool to design personalized and population-targeted vaccine epitopes (2020) (7)
- NHC-gold compounds mediate immune suppression through induction of AHR-TGFβ1 signalling in vitro and in scurfy mice (2020) (6)
- Cell‐mediated anti‐Gag immunity in pharmacologically induced functional cure of simian AIDS: a ‘bottleneck effect’? (2015) (5)
- Patient-derived HIV-1 Nef alleles reveal uncoupling of CD4 downregulation and SERINC5 antagonism functions of the viral pathogenesis factor. (2020) (4)
- The FDA-approved drug cobicistat synergizes with remdesivir to inhibit SARS-CoV-2 replication (2021) (3)
- Immunogenicity of personalized dendritic-cell therapy in HIV-1 infected individuals under suppressive antiretroviral treatment: interim analysis from a phase II clinical trial (2022) (3)
- Immunogenicity of Personalized Dendritic-cell Therapy in HIV-1 Infected Individuals Under Suppressive Antiretroviral Treatment: Interim Analysis From a Phase II Clinical Trial. (2021) (2)
- Genomic profiling of HIV-1 integration in microglia links viral insertions to TAD organization (2022) (2)
- Post-therapy viral set-point abatement following combined antiproliferative and immune-boosting interventions: results from a randomised clinical trial (2019) (2)
- A cure for AIDS: a matter of timing? (2013) (1)
- Investigational treatment suspension and enhanced cell-mediated immunity at rebound followed by drug-free remission of simian AIDS (2013) (1)
- Proteasomal degradation of PML protein is a stress response to HIV-1 replication and reactivation (2019) (0)
- Chloroquine and beyond: exploring anti-rheumatic drugs to reduce immune hyperactivation in HIV/AIDS (2015) (0)
- PS2-060. C-Myb And Irf-1 Play Opposite Role On Foxp3 Transcription (2011) (0)
- Genomic Profiling of HIV-1 Integration in Microglia Cells Links Viral Integration to TAD Organization (2022) (0)
- A scalable workflow to test "shock and kill" therapeutic approaches against the HIV-1 latent reservoir in blood cells ex vivo. (2023) (0)
- Pharmacologic topoisomerase-I inhibition causes DNA damage and mortality in activated CD4+ T cells (2018) (0)
- Progress, pitfalls, and path forward of drug repurposing for COVID-19 treatment (2022) (0)
- Safety and potential impact of auranofin on the viral reservoir in HIV positive individuals under mega-ART (2017) (0)
- Genomic profiling of HIV-1 integration in microglia cells links viral integration to the topologically associated domains. (2023) (0)
This paper list is powered by the following services:
Other Resources About Luca Shytaj
What Schools Are Affiliated With Luca Shytaj?
Luca Shytaj is affiliated with the following schools: